Sionna Therapeutics (SION) Amortizatization of Intangibles (2024 - 2026)
Sionna Therapeutics (SION) reported Amortizatization of Intangibles of $200000.0 for Q1 2026, down 71.31% on a YoY basis from $697000.0 in Q1 2025, and down 43.34% sequentially from $353000.0 in Q4 2025.
Sionna Therapeutics (SION) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Sionna Therapeutics (SION) has 3 years of Amortizatization of Intangibles data on file, last reported at $200000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 71.31% year-over-year to $200000.0; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (down 28.77% YoY), and the FY2025 full-year result was $3.1 million, up 1.7% from the prior year.
- Amortizatization of Intangibles slipped to $200000.0 in Q1 2026, from $353000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $1.2 million in Q2 2025 to a low of $111000.0 in Q1 2024.
- A 3-year average of $694777.8 and a median of $790000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles jumped 527.93% in 2025 and sank 71.31% in 2026, its largest moves.
- Tracing SION's Amortizatization of Intangibles over 3 years: stood at $790000.0 in 2024, then plunged by 55.32% to $353000.0 in 2025, then tumbled by 43.34% to $200000.0 in 2026.
- Business Quant data shows SION's Amortizatization of Intangibles at $200000.0 in Q1 2026, $353000.0 in Q4 2025, and $836000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Sionna Therapeutics | 2.05 Bn | 2.05 Bn | - | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | 353,000.00 |
| Dec 31, 2025 | 353,000.00 |
| Sep 30, 2025 | 836,000.00 |
| Sep 30, 2025 | 836,000.00 |
| Jun 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 697,000.00 |
| Mar 31, 2025 | 697,000.00 |
| Dec 31, 2024 | 790,000.00 |
| Dec 31, 2024 | 790,000.00 |
| Sep 30, 2024 | 997,000.00 |
| Sep 30, 2024 | 997,000.00 |
| Jun 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 111,000.00 |
| Mar 31, 2024 | 111,000.00 |